Eagle Pharmaceuticals Inc (OTCPK:EGRX)
$ 0.5 -0.0102 (-2%) Market Cap: 6.48 Mil Enterprise Value: - PE Ratio: 0 PB Ratio: 0 GF Score: 60/100

Eagle Pharmaceuticals Inc at Citi BioPharma Conference Transcript

Sep 07, 2023 / 12:00PM GMT
Release Date Price: $16.16 (-4.77%)
Michael Brock

Thanks, everybody, for joining us today. My name is Michael Brock, I'm a Managing Director in Citigroup's Healthcare Investment Banking Group. I'm focused on biopharma and I've been doing this for a couple of decades, all focused on biopharma. So it's great to have you here with us today, and I'm delighted to introduce the management team of Eagle Pharmaceuticals. So Scott Tarriff and Brian Cahill, is with us today, he's the Chief Financial Officer.

So what I'd like to do is maybe turn it over to the CEO and the CFO. So Scott, maybe lead us off with a little bit of a introduction of Eagle Pharma. How the company has evolved over time and how you sit currently today?

Scott L. Tarriff
Eagle Pharmaceuticals, Inc. - Founder, President, CEO & Director

Well, I'd love to. And thank you Mike. Thank you personally and Citi for inviting us. It's been just a fantastic conference so far and just honored to be here. I really do appreciate it.

So Eagle, what a great time to be associated with the company now. We've been in business, it's hard

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot